P/B Ratio

Search documents
GEHC or A: Which Is the Better Value Stock Right Now?
ZACKS· 2025-08-18 16:41
Core Viewpoint - Investors in the Medical - Products sector should consider GE HealthCare Technologies (GEHC) and Agilent Technologies (A) for potential value investment opportunities [1] Group 1: Zacks Rank and Earnings Outlook - GE HealthCare Technologies has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while Agilent Technologies has a Zacks Rank of 3 (Hold) [3] - The Zacks Rank system emphasizes companies with positive estimate revision trends, suggesting that GEHC has an improving earnings outlook [3] Group 2: Valuation Metrics - GEHC has a forward P/E ratio of 16.21, compared to Agilent's forward P/E of 21.33, indicating that GEHC may be undervalued [5] - The PEG ratio for GEHC is 2.80, while Agilent's PEG ratio is 3.62, further suggesting that GEHC offers better value based on expected earnings growth [5] - GEHC's P/B ratio is 3.44, significantly lower than Agilent's P/B of 5.52, reinforcing the notion of GEHC being more attractively valued [6] Group 3: Overall Value Assessment - GEHC has stronger estimate revision activity and more attractive valuation metrics than Agilent, making it the superior option for value investors at this time [7]
NWPX vs. KNF: Which Stock Is the Better Value Option?
ZACKS· 2025-08-12 16:41
Core Insights - NWPX Infrastructure (NWPX) is currently more attractive to value investors compared to Knife River (KNF) based on various financial metrics and analyst outlooks [1][3][7] Valuation Metrics - NWPX has a forward P/E ratio of 16.82, while KNF has a significantly higher forward P/E of 27.81 [5] - The PEG ratio for NWPX is 3.36, indicating a more favorable expected EPS growth rate compared to KNF's PEG ratio of 6.44 [5] - NWPX's P/B ratio stands at 1.26, contrasting with KNF's P/B ratio of 3.43, suggesting that NWPX is undervalued relative to its book value [6] Analyst Outlook - NWPX holds a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions, while KNF has a Zacks Rank of 5 (Strong Sell), reflecting a less favorable analyst outlook [3][7] - The Value grade for NWPX is B, whereas KNF has a Value grade of F, further supporting the conclusion that NWPX is the superior option for value investors [6][7]
KB or SMFG: Which Is the Better Value Stock Right Now?
ZACKS· 2025-08-01 16:41
Core Viewpoint - KB Financial (KB) is currently more attractive to value investors compared to Sumitomo Mitsui (SMFG) based on various financial metrics and analyst outlooks [1][3][7] Valuation Metrics - KB has a forward P/E ratio of 7.20, while SMFG has a forward P/E of 10.89 [5] - KB's PEG ratio is 0.61, indicating better expected EPS growth relative to its valuation compared to SMFG's PEG ratio of 0.67 [5] - KB's P/B ratio stands at 0.74, compared to SMFG's P/B of 0.90, suggesting KB is undervalued relative to its book value [6] Analyst Outlook - KB has a Zacks Rank of 2 (Buy), indicating positive earnings estimate revision trends, while SMFG has a Zacks Rank of 4 (Sell) [3][7] - The stronger estimate revision activity for KB suggests a more favorable analyst outlook compared to SMFG [7] Value Grades - KB has received a Value grade of A, while SMFG has a Value grade of C, reflecting KB's superior valuation metrics [6]
GLDD or DY: Which Is the Better Value Stock Right Now?
ZACKS· 2025-07-04 16:41
Core Insights - Great Lakes Dredge & Dock (GLDD) and Dycom Industries (DY) are both strong candidates for value investors in the Building Products - Heavy Construction sector [1] - Both companies currently hold a Zacks Rank of 1 (Strong Buy), indicating a positive earnings outlook due to favorable analyst estimate revisions [3] Valuation Metrics - GLDD has a forward P/E ratio of 12.61, while DY has a forward P/E of 26.19, suggesting GLDD may be undervalued compared to DY [5] - The PEG ratio for GLDD is 1.05, indicating a more favorable valuation relative to its expected earnings growth compared to DY's PEG ratio of 1.43 [5] - GLDD's P/B ratio is 1.69, significantly lower than DY's P/B of 5.72, further supporting GLDD's position as a more attractive value option [6] Value Grades - GLDD has received a Value grade of A, while DY has a Value grade of D, highlighting GLDD's superior valuation metrics [6]
XRAY vs. MMSI: Which Stock Is the Better Value Option?
ZACKS· 2025-06-16 16:41
Core Viewpoint - Investors in the Medical - Dental Supplies sector should consider Dentsply International (XRAY) as a potentially undervalued stock compared to Merit Medical (MMSI) [1] Group 1: Company Rankings and Valuation Metrics - Dentsply International has a Zacks Rank of 2 (Buy), while Merit Medical has a Zacks Rank of 4 (Sell), indicating a more favorable earnings estimate revision trend for XRAY [3] - XRAY has a forward P/E ratio of 8.25, significantly lower than MMSI's forward P/E of 27.73, suggesting XRAY may be undervalued [5] - The PEG ratio for XRAY is 1.12, while MMSI's PEG ratio is 2.70, further indicating XRAY's better valuation relative to expected earnings growth [5] Group 2: Additional Valuation Metrics - XRAY's P/B ratio is 1.55, compared to MMSI's P/B of 3.85, highlighting XRAY's more favorable market value relative to its book value [6] - These metrics contribute to XRAY's Value grade of A and MMSI's Value grade of D, reinforcing the view that XRAY is the better investment option for value investors [6]
GBOOY or BAM: Which Is the Better Value Stock Right Now?
ZACKS· 2025-06-02 16:46
Core Viewpoint - The analysis compares Grupo Financiero Banorte SAB de CV (GBOOY) and Brookfield Asset Management (BAM) to determine which stock is more attractive to value investors [1] Valuation Metrics - GBOOY has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while BAM has a Zacks Rank of 3 (Hold) [3] - GBOOY's forward P/E ratio is 8.03, significantly lower than BAM's forward P/E of 33.93 [5] - GBOOY has a PEG ratio of 0.94, compared to BAM's PEG ratio of 2.03, suggesting GBOOY is more favorably valued in terms of expected earnings growth [5] - GBOOY's P/B ratio is 1.82, while BAM's P/B ratio is 10.25, further indicating GBOOY's relative undervaluation [6] - GBOOY earns a Value grade of A, whereas BAM receives a Value grade of F, highlighting GBOOY's stronger valuation metrics [6] Conclusion - GBOOY is positioned as the superior value option due to its solid earnings outlook and favorable valuation figures compared to BAM [7]
XRAY vs. COO: Which Stock Should Value Investors Buy Now?
ZACKS· 2025-05-30 16:41
Core Viewpoint - Investors in the Medical - Dental Supplies sector should consider Dentsply International (XRAY) and The Cooper Companies (COO) for potential value opportunities, with XRAY currently showing stronger metrics and analyst outlook [1][3]. Valuation Metrics - Dentsply International (XRAY) has a forward P/E ratio of 8.64, while The Cooper Companies (COO) has a forward P/E of 20.09, indicating XRAY may be undervalued [5]. - The PEG ratio for XRAY is 1.17, compared to COO's PEG ratio of 2.02, suggesting XRAY has a more favorable growth outlook relative to its valuation [5]. - XRAY's P/B ratio is 1.62, while COO's P/B ratio is 1.96, further supporting XRAY's stronger valuation metrics [6]. Analyst Outlook - XRAY holds a Zacks Rank of 2 (Buy), indicating a more favorable earnings estimate revision activity compared to COO, which has a Zacks Rank of 3 (Hold) [3][7]. - The improving analyst outlook for XRAY suggests it is a more attractive option for value investors at this time [3][7].
ABM or CTAS: Which Is the Better Value Stock Right Now?
ZACKS· 2025-05-27 16:41
Core Insights - Investors are evaluating ABM Industries (ABM) and Cintas (CTAS) for potential value investment opportunities [1] - Both companies currently hold a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions and an improving earnings outlook [3] Valuation Metrics - ABM has a forward P/E ratio of 13.58, significantly lower than CTAS's forward P/E of 50.75, suggesting ABM may be undervalued [5] - The PEG ratio for ABM is 2.63, while CTAS has a PEG ratio of 3.85, indicating that ABM offers better value relative to its expected earnings growth [5] - ABM's P/B ratio stands at 1.79 compared to CTAS's P/B of 19.53, further supporting the notion that ABM is the superior value option [6] Value Grades - ABM has received a Value grade of B, while CTAS has a Value grade of D, highlighting the relative valuation strength of ABM [6]
SMGZY vs. MLNK: Which Stock Is the Better Value Option?
ZACKS· 2025-04-02 16:45
Core Insights - The article compares two Technology Services stocks, Smiths Group PLC (SMGZY) and MeridianLink (MLNK), to determine which is more attractive to value investors [1][3]. Valuation Metrics - Smiths Group PLC has a Zacks Rank of 2 (Buy), indicating a positive earnings estimate revision trend, while MeridianLink has a Zacks Rank of 3 (Hold) [3]. - SMGZY has a forward P/E ratio of 16.83, significantly lower than MLNK's forward P/E of 52.11, suggesting that SMGZY may be undervalued [5]. - The PEG ratio for SMGZY is 1.55, compared to MLNK's PEG ratio of 1.76, indicating a more favorable valuation relative to expected earnings growth [5]. - SMGZY's P/B ratio is 3.13, while MLNK's P/B ratio is 3.31, further supporting the notion that SMGZY is a better value option [6]. - Based on these metrics, SMGZY holds a Value grade of B, whereas MLNK has a Value grade of F, highlighting the relative undervaluation of SMGZY [6]. Conclusion - Overall, Smiths Group PLC is positioned as the superior value option due to its solid earnings outlook and more favorable valuation metrics compared to MeridianLink [7].
DGII or CSCO: Which Is the Better Value Stock Right Now?
ZACKS· 2025-03-24 16:45
Group 1 - The article compares Digi International (DGII) and Cisco Systems (CSCO) to determine which stock is more attractive to value investors [1] - DGII has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while CSCO has a Zacks Rank of 3 (Hold) [3] - Value investors analyze various traditional metrics to assess if a company is undervalued, including P/E ratio, P/S ratio, earnings yield, and cash flow per share [4] Group 2 - DGII has a forward P/E ratio of 14.42, while CSCO has a forward P/E of 16.22, suggesting DGII may be undervalued [5] - DGII's PEG ratio is 0.85, compared to CSCO's PEG ratio of 3.18, indicating better expected earnings growth for DGII [5] - DGII's P/B ratio is 1.80, significantly lower than CSCO's P/B of 5.27, further supporting DGII's valuation as more attractive [6] Group 3 - DGII's improving earnings outlook and favorable valuation metrics position it as the superior value option compared to CSCO [7]